Browse studies, page 1306
Page 1306 of 1,318, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Analytical profiling of mutations in quinolone resistance determining region of gyrA gene among UPEC. PloS one, 2018
- Population pharmacokinetics of oral levofloxacin in healthy volunteers and dosing optimization for multidrug-resistant tuberculosis therapy Biopharmaceutics & drug disposition, 2021
- An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in Han Chinese iScience, 2023
- Prediction of Antimicrobial Resistance in Gram-Negative Bacteria From Whole-Genome Sequencing Data Frontiers in microbiology, 2020
- Parallel-slipped π-π electron-donor-acceptor in adsorption process: Molecular dynamics simulation Journal of molecular graphics & modelling, 2022
- An experimental in silico study on COVID-19: Response of neutrophil-related genes to antibiotics Health science reports, 2022
- Synthesis and molecular docking study of some 3,4-dihydrothieno[2,3-d]pyrimidine derivatives as potential antimicrobial agents Bioorganic chemistry, 2019
- Isolation and Characterization of Werneria Chromene and Dihydroxyacidissimol from Burkillanthus malaccensis (Ridl.) Swingle Plants (Basel, Switzerland), 2022
- Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients Scientific reports, 2022
- Molecular detection of H. pylori antibiotic-resistant genes and molecular docking analysis FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020
- Antibacterial Potential of Novel Acetamide Derivatives of 2-Mercaptobenzothiazole: Synthesis and Docking Studies ACS omega, 2023
- Integrative analysis of levofloxacin-induced liver injury: Insights from pharmacovigilance, human liver organoids, and extracellular vesicle proteomics Toxicology and applied pharmacology, 2025
- Levofloxacin in Bone and Joint Infections: Development of an Application for Model-Informed Precision Dosing Clinical pharmacology and therapeutics, 2026
- In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis Scientific reports, 2022
- The effects of levofloxacin on rabbit fibroblast-like synoviocytes in vitro Toxicology and Applied Pharmacology, 2012
- In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe Clinical Microbiology and Infection, 2002
- In vitro activity of levofloxacin against gram-positive bacteria Chemotherapy, 1999
- Comparative In Vitro Activities of Linezolid, Telithromycin, Clarithromycin, Levofloxacin, Moxifloxacin, and Four Conventional Antimycobacterial Drugs against Mycobacterium kansasii Antimicrobial Agents and Chemotherapy, 2004
- In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis Antimicrobial Agents and Chemotherapy, 1996
- Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories Antimicrobial Agents and Chemotherapy, 2003
- Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model Antimicrobial Agents and Chemotherapy, 2001
- In-vitro activity of ofloxacin, levofloxacin and D-ofloxacin against staphylococci Journal of Antimicrobial Chemotherapy, 1996
- In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus PubMed, 2006
- Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models Acta Ophthalmologica, 2010
- Activities of Mutant Prevention Concentration-Targeted Moxifloxacin and Levofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model Antimicrobial Agents and Chemotherapy, 2003
- In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram- positive and gram-negative pathogens from respiratory tract infections Journal of Antimicrobial Chemotherapy, 1997
- Phenotypic Resistance of Staphylococcus aureus , Selected Enterobacteriaceae , and Pseudomonas aeruginosa after Single and Multiple In Vitro Exposures to Ciprofloxacin, Levofloxacin, and Trovafloxacin Antimicrobial Agents and Chemotherapy, 2001
- Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model Clinical Infectious Diseases, 2001
- In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic Fibrosis Antimicrobial Agents and Chemotherapy, 2009
- Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model Antimicrobial Agents and Chemotherapy, 1994
- Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages Antimicrobial Agents and Chemotherapy, 1994
- Effects of NorA Inhibitors on In Vitro Antibacterial Activities and Postantibiotic Effects of Levofloxacin, Ciprofloxacin, and Norfloxacin in Genetically Related Strains of Staphylococcus aureus Antimicrobial Agents and Chemotherapy, 1999
- Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin European Journal of Pharmaceutics and Biopharmaceutics, 1998
- Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms International Journal of Antimicrobial Agents, 2000
- In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis Antimicrobial Agents and Chemotherapy, 1995
- Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro Journal of Orthopaedic Research®, 2000
- Comparison of toxicities of moxifloxacin, cefuroxime, and levofloxacin to corneal endothelial cells in vitro Journal of cataract and refractive surgery, 2014
- Formulation and in vitro evaluation of size expanding gastro-retentive systems of levofloxacin hemihydrate International journal of pharmaceutics, 2014
- In vitro evaluation of tigecycline synergy testing with nine antimicrobial agents against Enterobacter cloacae clinical strains Frontiers in Microbiology, 2024
- Potential effectiveness of parenteral nemonoxacin in the treatment of Clostridioides difficile infections: in vitro, ex vivo, and mouse studies Frontiers in Microbiology, 2024
- Cannabidiol Demonstrates Remarkable Efficacy in Treating Multidrug-Resistant Enterococcus Faecalis Infections In Vitro and In Vivo TRENDS IN THE SCIENCES, 2024
- Comparative in vitro activity of Delafloxacin and other antimicrobials against isolates from patients with acute bacterial skin, skin-structure infection and osteomyelitis Brazilian Journal of Infectious Diseases, 2024
- Levofloxacin: formulation and in-vitro evaluation of alginate and chitosan nanospheres Egyptian Pharmaceutical Journal, 2015
- Increased in vitro antimicrobial resistance of Mycoplasma pneumoniae isolates obtained from children in Beijing, China, in 2023 Frontiers in Cellular and Infection Microbiology, 2024
- Comparative in vitro activity of ciprofloxacin and levofloxacin against isolated uropathogens in Ghana: a pilot study The Pan African Medical Journal, 2018
- Efficacy of levofloxacin against biofilms of Pseudomonas aeruginosa isolated from patients with respiratory tract infections in vitro MicrobiologyOpen, 2018
- Design and characterization of nanocarriers loaded with Levofloxacin for enhanced antimicrobial activity; physicochemical properties, in vitro release and oral acute toxicity Brazilian Journal of Pharmaceutical Sciences, 2019
- Potent synergistic combination of rosuvastatin and levofloxacin against Staphylococcus aureus: in vitro and in vivo study Journal of Applied Microbiology, 2020
- In vitro and in vivo combined antibacterial effect of levofloxacin/silver co-loaded electrospun fibrous membranes Journal of materials chemistry. B, 2017
- Combined Effect of Levofloxacin and N-Acetylcysteine against Enterococcus faecalis Biofilm for Regenerative Endodontics: An in Vitro Study Iranian endodontic journal, 2019
- Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design, In-vitro Characterization, Antibacterial Evaluation and Scintigraphy Study Iranian journal of pharmaceutical research, 2020
- Preparation of levofloxacin loaded in situ gel for sustained ocular delivery: in vitro and ex vivo evaluations Drug Development and Industrial Pharmacy, 2019
- Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study Journal of Antimicrobial Chemotherapy, 2019
- Assessment of the in vitro activity of azithromycin niosomes alone and in combination with levofloxacin on extensively drug-resistant Klebsiella pneumoniae clinical isolates Brazilian Journal of Microbiology, 2021
- Synergistic effect of chlorogenic acid and levofloxacin against Klebsiella pneumonia infection in vitro and in vivo Scientific Reports, 2020
- Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study International Journal of Biological Macromolecules, 2021
- Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group Diagnostic microbiology and infectious disease, 1996
- Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using In Vitro and In Vivo Models of Q Fever Antimicrobial Agents and Chemotherapy, 2021
- Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin Journal of chemotherapy, 1994
- In-vitro cytotoxicity, synergistic antibacterial activity and interaction studies of imidazolium-based ionic liquids with levofloxacin Journal of Molecular Liquids, 2021
- Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates Journal of Antimicrobial Chemotherapy, 2000
- Formulation, Optimization, in vitro and in-vivo evaluation of levofloxacin hemihydrate Floating Tablets Brazilian Journal of Pharmaceutical Sciences, 2022
- Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017
- Spanlastic-laden in situ gel as a promising approach for ocular delivery of Levofloxacin: In-vitro characterization, microbiological assessment, corneal permeability and in-vivo study International Journal of Pharmaceutics: X, 2023
- Precision bacterial immunotherapy: an integrated mechanistic taxonomy and translational roadmap against antimicrobial resistance Frontiers in immunology, 2025
- Mannose-modified miR-223 nanoparticles remodel pathological microenvironment to suppress inflammation and angiogenesis for neovascular AMD therapy International journal of pharmaceutics: X, 2026
- TXA11114: Discovery of an In Vivo Efficacious Efflux Pump Inhibitor (EPI) That Potentiates Levofloxacin Against Pseudomonas aeruginosa Antibiotics (Basel, Switzerland), 2026
- Efficacy and Safety of Minocycline-Containing Bismuth Quadruple Therapies Versus Standard First-Line Bismuth Quadruple Therapies for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis Infectious disease reports, 2026
- Recurrent giant neurofibroma of the posterior neck and upper back with failed primary grafting and salvage reconstruction: a case report Frontiers in surgery, 2026
- Rheological modulation and drug delivery efficiency of carbon nanotube-integrated guar gum hydrogels Scientific reports, 2026
- Formulation and clinical translation of inhalable nanomedicines for the treatment and prevention of pulmonary infectious diseases Drug delivery and translational research, 2025
- Global Profile of Drug Resistance Related to Helicobacter pylori Infection in Children: A Systematic Review and Meta-Analysis Health science reports, 2025
- Levofloxacin-loaded surfactant nanocarriers: a computational study Nanoscale advances, 2026
- The COVID-19 pandemic: an underlying factor for increased Stenotrophomonas maltophilia infections-A literature review and case study analysis Frontiers in microbiology, 2025
- Antimicrobial research productivity in Lebanon: A PubMed-Based bibliometric analysis New microbes and new infections, 2025
- From Pelvis to Groin: Non-Communicating Rudimentary Uterine Horn and Endometriosis Presenting as an Inguinal Hernia in a Woman with a Solitary Pelvic Kidney International journal of women's health, 2026
- Applications and challenges of 3D printing in female reproductive system research 3D printing in medicine, 2025
- 3D Printing for Pelvic Organ Prolapse Management: A Narrative Review of Emerging Applications Bioengineering (Basel, Switzerland), 2026
- Design and Production of Respirable Effervescent Microparticles to Enhance Drug Penetration Through Lung Mucus Pharmaceutics, 2026
- Nanoencapsulation of Anise oil and evaluation of its antimicrobial and antioxidant effects to propose for food preservation Discover nano, 2026
- Persistent Pathogens Following Minimally Invasive Surgery: Is It Time to Rethink Aldehyde-Based Disinfection? Cureus, 2025
- Synchronous Gastric Signet-Ring Cell Adenocarcinoma and Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Treated With Robotic Total Gastrectomy: A Case Report and Literature Review Cureus, 2026
- Macroheterocycle-functionalized PVDF meshes with hybrid nanocomposite coatings for antibacterial wound care RSC advances, 2026
- Fusobacterium necrophorum Brain Abscess With Concurrent Nasopharyngeal Detection of Mycoplasma pneumoniae: A Case Report Cureus, 2026
- Characterization of blaNDM-1 and blaOXA-23-Type Carbapenemases in Acinetobacter baumannii Isolated from Post-Surgical Patients Antibiotics (Basel, Switzerland), 2026
- Electrospun Zn-cobimetinib-levofloxacin-PVA/PVP nanofibers for skin-targeted anticancer and antimicrobial applications RSC advances, 2026
- Structure of chloramphenicol-bound MexB reveals residues in the distal binding pocket that are critical for substrate recognition Journal of biochemistry, 2026
- Surgical site infection due to Mycobacterium wolinskyi after inguinal hernia surgery: A case report and review of the literature Journal of clinical tuberculosis and other mycobacterial diseases, 2026
- Development and Validation of Spectrophotometric Method for Determination of Levofloxacin in Rat Plasma Molecules (Basel, Switzerland), 2026
- The Impact of Surfactants in Tailoring Nanostructured Lipid Carriers for Inhaled Levofloxacin ACS omega, 2026
- Enhancing the antimicrobial efficacy of polyester hernia meshes via layer-by-layer chitosan surface modification Hernia : the journal of hernias and abdominal wall surgery, 2026
- Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan The Journal of antimicrobial chemotherapy, 2000
- In vitro induction and selection of fluoroquinolone-resistant mutants in Elizabethkingia anophelis Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2024
- Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates Future microbiology, 2018
- Preparation oral levofloxacin colon-specific microspheres delivery: in vitro and in vivo studies Drug delivery, 2016
- In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase Journal of chemotherapy (Florence, Italy), 2016
- In vitro susceptibility of a penicillin-resistant and tolerable isolate of Streptococcus pneumoniae to combination therapy Journal of infection in developing countries, 2015
- Synthesis and biological evaluation of novel N, N'-diarylurea derivatives as potent antibacterial agents against MRSA. Bioorganic & medicinal chemistry letters, 2022
- Fluoroquinolones and propionic acid derivatives induce inflammatory responses in vitro Cell biology and toxicology, 2018
- Levofloxacin exerts broad-spectrum anticancer activity via regulation of THBS1, LAPTM5, SRD5A3, MFAP5 and P4HA1 Anti-cancer drugs, 2022
